BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625), developers of the first-of-its-kind artificial liver device, today announced the addition of Dr. Zorina Pitkin -- an accomplished expert in regulatory affairs/quality systems related to cell-based products and bioartificial liver devices -- to the Company’s Scientific Advisory Board.
